TRexBio
Developer of biotechnology therapeutics designed to treat immune-mediated diseases. The company maps human tissue's behavior to disease processes, allowing it to identify and characterize novel target...
Valuation
$0
Share Price
N/A
Total Raised
$172.1M
Last Round
N/A